Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential

Pharmacology Biochemistry and Behavior

Volumn 133, Issue , 2015, Pages 31-36

  Botanas, Chrislean Jun ^a   De La Peña, June Bryan ^a   Dela Peña, Irene Joy ^a   Tampus, Reinholdgher ^a   Yoon, Robin ^a   Kim, Hee Jin ^a   Lee, Yong Sup ^b   Jang, Choon Gon ^c   Cheong, Jae Hoon ^a  

^a Sahmyook University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Addiction; Conditioned place preference; Designer drugs; Ketamine; Methoxetamine; Self administration

Indexed keywords

KETAMINE; METHOXETAMINE; N METHYL DEXTRO ASPARTIC ACID; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; 2-(3-METHOXYPHENYL)-2-(ETHYLAMINO)CYCLOHEXANONE; CYCLOHEXANONE DERIVATIVE; CYCLOHEXYLAMINE DERIVATIVE;

ACCLIMATIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG CONTROL; DRUG DEPENDENCE; DRUG FATALITY; DRUG MONITORING; DRUG SELF ADMINISTRATION; FATALITY; HABITUATION; LOCOMOTION; MALE; MUSCLE TONE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; ANIMAL; CONDITIONING; DOSE RESPONSE; DRUG EFFECTS; MOTOR ACTIVITY; PSYCHOLOGY;

RATTUS;

ANIMALS; CONDITIONING (PSYCHOLOGY); CYCLOHEXANONES; CYCLOHEXYLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; KETAMINE; MALE; MOTOR ACTIVITY; RATS; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 84926199010     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.03.007     Document Type: Article

References (39)

1. Advisory Council on the Misuse of Drugs (ACMD) Methoxetamine report https://www.gov.uk/government/publications/advisory-council-on-the-misuse-of-drugs-acmd-methoxetamine-report-2012 2012 [Accessed January 8, 2015]
2. A. Becker, B. Peters, H. Schroeder, T. Mann, G. Huether, and G. Grecksch Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 27 2003 687 700
3. T. Bey, and A. Patel Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug Calif J Emerg Med 8 2007 9
4. S. Bradbury, J. Bird, J. Colussi-Mas, M. Mueller, G. Ricaurte, and S. Schenk Acquisition of MDMA self-administration: pharmacokinetic factors and MDMA-induced serotonin release Addict Biol 19 2014 874 884
5. K. Brebner, S. Ahn, and A.G. Phillips Attenuation of d-amphetamine self-administration by Baclofen in the rat: behavioral and neurochemical correlates Psychopharmacology (Berl) 177 2005 409 417
6. M. Brocco, A. Dekeyne, S. Veiga, S. Girardon, and M.J. Millan Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents Pharmacol Biochem Behav 71 2002 667 680
7. O. Corazza, F. Schifano, P. Simonato, S. Fergus, S. Assi, and J. Stair et al. Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine Hum Psychopharmacol 27 2012 145 149
8. O. Corazza, S. Assi, and F. Schifano From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine CNS Neurosci Ther 19 2013 454 460
9. J.B.I. de la Peña, H.C. Lee, I.C. de la Peña, T.S. Woo, S.Y. Yoon, and H.L. Lee et al. Rewarding and reinforcing effects of the NMDA receptor antagonist-benzodiazepine combination, Zoletil®: difference between acute and repeated exposure Behav Brain Res 233 2012 434 442
10. J.B. de la Peña, S.Y. Yoon, I.C. de la Peña, H.L. Lee, I.J. IdlP, and J.H. Cheong Pre-exposure to related substances induced place preference and self-administration of the NMDA receptor antagonist-benzodiazepine combination, Zoletil Behav Pharmacol 24 2013 20 28
11. J.B. de la Peña, H.M. Ahsan, I.J. dela Peña, H.B. Park, H.J. Kim, and A. Sohn et al. Propofol pretreatment induced place preference and self-administration of the tiletamine-zolazepam combination: implication on drug of abuse substitution Am J Drug Alcohol Abuse 40 2014 321 326
12. M.T. De Luca, and A. Badiani Ketamine self-administration in the rat: evidence for a critical role of setting Psychopharmacology (Berl) 214 2011 549 556
13. G. Di Chiara Nucleus accumbens shell and core dopamine: differential role in behavior and addiction Behav Brain Res 137 2002 75 114
14. G. Di Chiara, and V. Bassareo Reward system and addiction: what dopamine does and doesn't do Curr Opin Pharmacol 7 2007 69 76
15. European Monitoring for Drugs and Drug Addiction (EMCDDA) Polydrug use: patterns and responses 2009 Publications Office of the European Union Lisbon [ http://www.emcdda.europa.eu/publications/selected-issues/polydrug-use. Accessed January 13, 2015]
16. European Monitoring for Drugs and Drug Addiction (EMCDDA) Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) in the framework of the council decision on new psychoactive substances 2014 Publication Office of the European Union Luxembourg [ http://www.emcdda.europa.eu/publications/risk-assessment/methoxetamine. Accessed January 13, 2015]
17. L. Fattore, and W. Fratta Beyond THC: the new generation of cannabinoid designer drugs Front Behav Neurosci 5 2011
18. S. Jones, and A. Bonci Synaptic plasticity and drug addiction Curr Opin Pharmacol 5 2005 20 25
19. A. Kjellgren, and K. Jonsson Methoxetamine (MXE) - a phenomenological study of experiences induced by a "legal high" from the internet J Psychoactive Drugs 45 2013 276 286
20. M. Ko, J. Terner, S. Hursh, J. Woods, and G. Winger Relative reinforcing effects of three opioids with different durations of action J Pharmacol Exp Ther 301 2002 698 704
21. R.-M. Liao, Y.-H. Chang, S.-H. Wang, and C.-H. Lan Distinct accumbal subareas are involved in place conditioning of amphetamine and cocaine Life Sci 67 2000 2033 2043
22. E.A. Loh, and D.C. Roberts Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin Psychopharmacology (Berl) 101 1990 262 266
23. M. Marcus, J. Mathe, G. Nomikos, and T. Svensson Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens Neuropharmacology 40 2001 482 490
24. M.R. Meyer, M. Bach, J. Welter, M. Bovens, A. Turcant, and H.H. Maurer Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn Anal Bioanal Chem 405 2013 6307 6321
25. C.J. Morgan, and H.V. Curran Ketamine use: a review Addiction 107 2012 27 38
26. H. Morris, and J. Wallach From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs Drug Test Anal 6 2014 614 632
27. D. Mueller, and J. Stewart Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction Behav Brain Res 115 2000 39 47
28. C.P. Müller, and J.R. Homberg The role of serotonin in drug use and addiction Behav Brain Res 277 2015 146 192
29. Y. Noda, Y. Miyamoto, T. Mamiya, H. Kamei, H. Furukawa, and T. Nabeshima Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly J Pharmacol Exp Ther 286 1998 44 51
30. L.V. Panlilio, and C.W. Schindler Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats Psychopharmacology (Berl) 150 2000 61 66
31. H.O. Pettit, and J.B. Justice Jr. Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis Pharmacol Biochem Behav 34 1989 899 904
32. B.L. Roth, S. Gibbons, W. Arunotayanun, X.-P. Huang, V. Setola, and R. Treble et al. The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor PLoS One 8 2013 e59334
33. T.S. Shippenberg, and G. Koob Recent advances in animal models of drug addiction and alcoholism Neuropsychopharmacology 2002 1381 1397
34. F.L. Smith, D.S. Yu, D.G. Smith, A.P. Leccese, and W.H. Lyness Dietary tryptophan supplements attenuate amphetamine self-administration in the rat Pharmacol Biochem Behav 25 1986 849 855
35. K.A. Trujillo, M.L. Smith, B. Sullivan, C.Y. Heller, C. Garcia, and M. Bates The neurobehavioral pharmacology of ketamine: implications for drug abuse, addiction, and psychiatric disorders ILAR J 52 2011 366 378
36. E. Valjent, J. Bertran-Gonzalez, B. Aubier, P. Greengard, D. Hervé, and J.-A. Girault Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol Neuropsychopharmacology 35 2010 401
37. G. Winger, S. Hursh, K. Casey, and J. Woods Relative reinforcing strength of three N-methyl-d-aspartate antagonists with different onsets of action J Pharmacol Exp Ther 301 2002 690 697
38. D. Xu, Z. Mo, K. Yung, Y. Yang, and A. Leung Individual and combined effects of methamphetamine and ketamine on conditioned place preference and NR1 receptor phosphorylation in rats Neurosignals 15 2008 322 331
39. J.B. Zawilska Methoxetamine - a novel recreational drug with potent hallucinogenic properties Toxicol Lett 230 2014 402 407